It's all g_老虎社区_美港股上老虎

PhewyPompipi
2021-11-29

It's all good news to us investors.

BioNTech Is Working On an Omicron Version of Its Covid Shot

BioNTech SE is working to adapt its Covid-19 vaccine to address the omicron variant and expects to h

BioNTech Is Working On an Omicron Version of Its Covid Shot

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":600451700,"tweetId":"600451700","gmtCreate":1638191764950,"gmtModify":1638191765142,"author":{"id":4087475573507020,"idStr":"4087475573507020","authorId":4087475573507020,"authorIdStr":"4087475573507020","name":"PhewyPompipi","avatar":"https://static.tigerbbs.com/10a26daea90fabdea45079a2a026323c","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":9,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>It's all good news to us investors.&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>It's all good news to us investors.&nbsp;</p></body></html>","text":"It's all good news to us investors.","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/600451700","repostId":1173904581,"repostType":4,"repost":{"id":"1173904581","kind":"news","pubTimestamp":1638186226,"share":"https://www.laohu8.com/m/news/1173904581?lang=&edition=full","pubTime":"2021-11-29 19:43","market":"us","language":"en","title":"BioNTech Is Working On an Omicron Version of Its Covid Shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1173904581","media":"Bloomberg","summary":"BioNTech SE is working to adapt its Covid-19 vaccine to address the omicron variant and expects to h","content":"<p>BioNTech SE&nbsp;is working to adapt its Covid-19 vaccine to address the omicron variant and expects to have a new version ready within 100 days if necessary.</p>\n<p>BioNTech SE&nbsp;stock&nbsp;jumped&nbsp;5%&nbsp;in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/df27de31843e0340df06283dfd4547ae\" tg-width=\"850\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p>\n<p>The company has started development in order to move as quickly as possible, BioNTech said in a statement. The first steps of developing a new vaccine overlap with the&nbsp;research&nbsp;necessary in order to evaluate whether a new shot will be needed -- a process that began last Thursday as soon as&nbsp;news&nbsp;of the new variant began to spread around the world.</p>\n<p>The German biotech and its Covid vaccine partner&nbsp;Pfizer Inc.&nbsp;put plans into place months ago to ensure a new version of their shot could ship within 100 days if necessary. The omicron variant has raised concerns around the world, with countries implementing travel bans to buy time as researchers race to study whether it will evade vaccines and spread more rapidly. It will probably take weeks to understand the full impact of the variant, scientists have said.</p>\n<p>Moderna Inc., which makes another messenger-RNA vaccine for Covid, has begun a similar&nbsp;process&nbsp;of evaluation and development, should a new shot be necessary. Both companies have said it should become clear within weeks whether an adapted vaccine will be needed.</p>\n<p>Vaccinated people should still be protected, depending on how long ago they got their shots, and for now the best advice is to take one of the current Covid vaccines, Moderna Chief Medical Officer Paul Burton said on Sunday on the BBC’s “Andrew Marr Show.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech Is Working On an Omicron Version of Its Covid Shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech Is Working On an Omicron Version of Its Covid Shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-29 19:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-29/biontech-is-working-on-an-omicron-version-of-its-covid-shot?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BioNTech SE is working to adapt its Covid-19 vaccine to address the omicron variant and expects to have a new version ready within 100 days if necessary.\nBioNTech SE stock jumped 5% in premarket ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-29/biontech-is-working-on-an-omicron-version-of-its-covid-shot?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-29/biontech-is-working-on-an-omicron-version-of-its-covid-shot?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173904581","content_text":"BioNTech SE is working to adapt its Covid-19 vaccine to address the omicron variant and expects to have a new version ready within 100 days if necessary.\nBioNTech SE stock jumped 5% in premarket trading.\n\nThe company has started development in order to move as quickly as possible, BioNTech said in a statement. The first steps of developing a new vaccine overlap with the research necessary in order to evaluate whether a new shot will be needed -- a process that began last Thursday as soon as news of the new variant began to spread around the world.\nThe German biotech and its Covid vaccine partner Pfizer Inc. put plans into place months ago to ensure a new version of their shot could ship within 100 days if necessary. The omicron variant has raised concerns around the world, with countries implementing travel bans to buy time as researchers race to study whether it will evade vaccines and spread more rapidly. It will probably take weeks to understand the full impact of the variant, scientists have said.\nModerna Inc., which makes another messenger-RNA vaccine for Covid, has begun a similar process of evaluation and development, should a new shot be necessary. Both companies have said it should become clear within weeks whether an adapted vaccine will be needed.\nVaccinated people should still be protected, depending on how long ago they got their shots, and for now the best advice is to take one of the current Covid vaccines, Moderna Chief Medical Officer Paul Burton said on Sunday on the BBC’s “Andrew Marr Show.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":425,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":29,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

BioNTech Is Working On an Omicron Version of Its Covid Shot

评论（1）

热议股票